title: Reply to B. Jeremic et al.
authors.affiliation: Princess Margaret Cancer Center, Toronto, Ontario, Canada andrea.bezjak@rmp.uhn.on.ca.
authors.forename: Andrea
authors.initials: A
authors.lastname: Bezjak
authors.affiliation: American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Sarah
authors.initials: S
authors.lastname: Temin
authors.affiliation: Massachusetts General Hospital, Boston, MA.
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Azzoli
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D008297:Male; D011878:Radiotherapy / Q000592:standards*; D018714:Radiotherapy, Adjuvant / Q000592:standards*